Clinical Supplies In Developing Countries
Webinar Summary: With biopharma companies hitching their long-term growth plans to success in emerging markets, they can ill-afford for logistical difficulties in new territories to scuttle their ambitions. This is a real risk, though. Transporting drugs to patients in Brazil, India and China is fraught with multiple challenges for which experience of shipping products in the West offers scant preparation.
From the lack of rail infrastructure and paved roads in Brazil, to the cold-chain limitations of rural India, the supply chain challenges of emerging markets are diverse and significant. What they are not is insurmountable.
For a preview of the webinar, listen to this brief conversation with a Catalent expert